Legal Representation
Attorney
Andrew N. Spivak
USPTO Deadlines
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 20, 2025 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Nov 18, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 18, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 15, 2025 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Nov 12, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 22, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 22, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 20, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 20, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 16, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 15, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 15, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 15, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 5, 2025 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Aug 19, 2025 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Aug 19, 2025 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Jul 15, 2025 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Jul 14, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 14, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 31, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Mar 31, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 27, 2025 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer
Class 042
Research and development services in the field of antibodies; research and development services in the field of antibody technology; laboratory research and analysis in the field of the production of antibodies; scientific and technology services, namely, scientific research, testing and analysis in the field of antibodies and research and design services related thereto; industrial analysis services and industrial research services in the field of antibodies; industrial analysis and industrial research services in the field of chemistry
Additional Information
Translation
The wording "SADA PRIT" has no meaning in a foreign language.
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PRIT"